European Pharmaceutical Review

SEPTEMBER 14, 2023

Once operational in early 2025, the partnership will reduce emissions by an estimated 20,000 tonnes CO 2 equivalent (CO 2 e). Alongside this move, AstraZeneca’s investment in major energy efficiencies in its operations, brings the total of its financial commitment to net zero, to £100 million.

Manufacturing 111

Manufacturing Medicine Pharmaceutical manufacturing Pharma 111

pharmaphorum

NOVEMBER 25, 2022

The Parma site, as yet only nine months into construction, is due to become operational from 2024, with FDA, IFA, and EMA approvals due to be sought for 2025. Going beyond the standards of care; improving drug safety and efficacy. But to make people safe requires a lot of research.

Pharmaceutical 94

Pharmaceutical Manufacturing Medicine Competition 94

PM360

AUGUST 9, 2022

billion in 2025. Needles cause patients pain, anxiety, pose safety risks, and for some people receiving injection therapy is a traumatic experience. Launched in July 2021, Prescryptive Health provides next-generation, mobile market access and medication adherence solutions for pharmaceutical manufacturers.

Prescription 105

Prescription Medical Patients Side effects 105